NetComposites
Attwater

Crescent Capital Investment in Cirrus Industries

28 August 2001

Crescent Capital Investments, Inc. has arranged for the acquisition through its affiliates 61% ownership of Cirrus Industries, Inc., the second largest manufacturer of single-engine, piston-powered, general aviation aircraft in the world.

Cirrus Industries based in Duluth, Minnesota, is known for innovative design, construction, and attention to safety. Cirrus developed the first production airplane that contains its own parachute. If an airplane experiences engine trouble, the pilot or any passenger can deploy the parachute, which allows the entire aircraft to float to the ground.

Cirrus aircraft are produced primarily from composite materials, incorporating resin-impregnated fiberglass, instead of older traditional techniques of cutting and riveting aluminum sheets to a metal frame. Composite construction contributes to superior aerodynamics, which results in better performance. The planes are easier to fly due to advanced avionics and advanced autopilot technology incorporated into each aircraft. Ergonomically, the plane's interior is similar to a luxury automobile.

Cirrus aircraft were named one of ""America's 50 Best Products"" and Best Private Airplane by Forbes Magazine. The aircraft have received numerous design awards .





Share this story


Related / You might like...

Cristex Keeps Pace With Composites Sector Thanks to ‘Limitless' Zünd G3 Cutter

Cristex Composites Materials has recently expanded its product offering with the addition of a new Zünd G3 precision cutting system, enabling the company to offer its customers an enhanced cut quality and precision service.

Bindatex Showcasing New Thermoplastic UD Tape Splicing Capability At JEC

Bindatex  will showcase its new thermoplastic splicing capability at JEC World 2019.

New Large Scale Resin Infusion Capabilities at NCC

The National Composites Centre (NCC) and Composite Integration celebrate the successful completion of a year-long project to design and deliver a state-of-the-art, first of its kind, Large Scale Resin Infusion (LSRI) technology.